|
1.
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Song J, Chang I, Chen Z, Kang M and Wang
CY: Characterization of side populations in HNSCC: highly invasive,
chemoresistant and abnormal Wnt signaling. PLoS One. 5:e114562010.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Krishnamurthy S and Nor JE: Orosphere
assay: a method for propagation of head and neck cancer stem cells.
Head Neck. 35:1015–1021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Campos MS, Neiva KG, Meyers KA,
Krishnamurthy S and Nor JE: Endothelial derived factors inhibit
anoikis of head and neck cancer stem cells. Oral Oncol. 48:26–32.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Krishnamurthy S and Nor JE: Head and neck
cancer stem cells. J Dent Res. 91:334–340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Zhang Z, Filho MS and Nor JE: The biology
of head and neck cancer stem cells. Oral Oncol. 48:1–9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ginos MA, Page GP, Michalowicz BS, et al:
Identification of a gene expression signature associated with
recurrent disease in squamous cell carcinoma of the head and neck.
Cancer Res. 64:55–63. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lin J, Guan Z, Wang C, et al: Id1
regulates the survival of HNSCC via the NF-κB/survivin and PI3K/Akt
signaling pathways. Clin Cancer Res. 16:77–87. 2010.
|
|
9.
|
Sun W, Guo MM, Han P, et al: Id-1 and the
p65 subunit of NF-kappaB promote migration of nasopharyngeal
carcinoma cells and are correlated with poor prognosis.
Carcinogenesis. 33:810–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Yuen HF, Chan YP, Chan KK, et al: Id-1 and
Id-2 are markers for metastasis and prognosis in oesophageal
squamous cell carcinoma. Br J Cancer. 97:1409–1415. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW
and Wong YC: Id-1 expression promotes cell survival through
activation of NF-kappaB signalling pathway in prostate cancer
cells. Oncogene. 22:4498–4508. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ling MT, Lau TC, Zhou C, et al:
Overexpression of Id-1 in prostate cancer cells promotes
angiogenesis through the activation of vascular endothelial growth
factor (VEGF). Carcinogenesis. 26:1668–1676. 2005. View Article : Google Scholar
|
|
13.
|
Caicedo-Granados EE, Wuertz BR and Ondrey
FG: Enforced expression of nuclear factor kappa B in p53 deficient
keratinocytes induces cell cycle, angiogenic potential and
tumorigenesis. Oral Oncol. 48:303–310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Alani RM, Hasskarl J, Grace M, Hernandez
MC, Israel MA and Munger K: Immortalization of primary human
keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad
Sci USA. 96:9637–9641. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Hamajima Y, Komori M, Preciado DA, et al:
Id1 induces proliferation of keratinocytes via the NF-kB/cyclin D1
pathway: the pathological basis for cholesteatoma. Cell
Proliferation. 43:457–463. 2010.PubMed/NCBI
|
|
16.
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
18.
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Singh J, Ling LE, Sawyer JS, Lee WC, Zhang
F and Yingling JM: Transforming the TGFbeta pathway: convergence of
distinct lead generation strategies on a novel kinase pharmacophore
for TbetaRI (ALK5). Curr Opin Drug Discov Devel. 7:437–445.
2004.PubMed/NCBI
|
|
20.
|
Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL
and Wu CL: Oct-3/4 expression reflects tumor progression and
regulates motility of bladder cancer cells. Cancer Res.
68:6281–6291. 2008. View Article : Google Scholar
|
|
21.
|
Chiou SH, Yu CC, Huang CY, et al: Positive
correlations of Oct-4 and Nanog in oral cancer stem-like cells and
high-grade oral squamous cell carcinoma. Clin Cancer Res.
14:4085–4095. 2008. View Article : Google Scholar
|
|
22.
|
Bao S, Wu Q, Sathornsumetee S, et al: Stem
cell-like glioma cells promote tumor angiogenesis through vascular
endothelial growth factor. Cancer Res. 66:7843–7848. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Diehn M, Cho RW and Clarke MF: Therapeutic
implications of the cancer stem cell hypothesis. Semin Radiat
Oncol. 19:78–86. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Corbeil D, Fargeas CA and Huttner WB: Rat
prominin, like its mouse and human orthologues, is a pentaspan
membrane glycoprotein. Biochem Biophys Res Commun. 285:939–944.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Corbeil D, Roper K, Fargeas CA, Joester A
and Huttner WB: Prominin: a story of cholesterol, plasma membrane
protrusions and human pathology. Traffic. 2:82–91. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Yin AH, Miraglia S, Zanjani ED, et al:
AC133, a novel marker for human hematopoietic stem and progenitor
cells. Blood. 90:5002–5012. 1997.
|
|
27.
|
Corbeil D, Roper K, Hellwig A, et al: The
human AC133 hematopoietic stem cell antigen is also expressed in
epithelial cells and targeted to plasma membrane protrusions. J
Biol Chem. 275:5512–5520. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Shmelkov SV, St Clair R, Lyden D and Rafii
S: AC133/CD133/Prominin-1. Int J Biochem Cell Biol. 37:715–719.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Salven P, Mustjoki S, Alitalo R, Alitalo K
and Rafii S: VEGFR-3 and CD133 identify a population of
CD34+lymphatic/vascular endothelial precursor cells.
Blood. 101:168–172. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Wu A, Oh S, Wiesner SM, et al: Persistence
of CD133+cells in human and mouse glioma cell lines:
detailed characterization of GL261 glioma cells with cancer stem
cell-like properties. Stem Cells Dev. 17:173–184. 2008.
|
|
31.
|
Wu A, Wiesner S, Xiao J, et al: Expression
of MHC I and NK ligands on human CD133+glioma cells:
possible targets of immunotherapy. J Neurooncol. 83:121–131. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Wu CJ: Immunologic targeting of the cancer
stem cell. StemBook (Internet). Cambridge, MA: Harvard Stem Cell
Institute; Dec 15–2008
|
|
33.
|
Damek-Poprawa M, Volgina A, Korostoff J,
et al: Targeted inhibition of CD133+cells in oral cancer
cell lines. J Dent Res. 90:638–645. 2011. View Article : Google Scholar
|
|
34.
|
Chen YS, Wu MJ, Huang CY, et al: CD133/Src
axis mediates tumor initiating property and epithelial-mesenchymal
transition of head and neck cancer. PLoS One. 6:e280532011.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Miller J, Dakic A, Chen R, et al: HPV16 E7
protein and hTERT proteins defective for telomere maintenance
cooperate to immortalize human keratinocytes. PLoS Pathog.
9:e10032842013. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Park NH, Min BM, Li SL, Huang MZ, Cherick
HM and Doniger J: Immortalization of normal human oral
keratinocytes with type 16 human papillomavirus. Carcinogenesis.
12:1627–1631. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Cordisco S, Maurelli R, Bondanza S, et al:
Bmi-1 reduction plays a key role in physiological and premature
aging of primary human keratinocytes. J Invest Dermatol.
130:1048–1062. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Lessard J and Sauvageau G: Bmi-1
determines the proliferative capacity of normal and leukaemic stem
cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Molofsky AV, Pardal R, Iwashita T, Park
IK, Clarke MF and Morrison SJ: Bmi-1 dependence distinguishes
neural stem cell self-renewal from progenitor proliferation.
Nature. 425:962–967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Itakura M, Mori S, Park NH and Bonavida B:
Both HPV and carcinogen contribute to the development of resistance
to apoptosis during oral carcinogenesis. Int J Oncol. 16:591–597.
2000.PubMed/NCBI
|
|
42.
|
Yasmeen A, Bismar TA, Kandouz M, Foulkes
WD, Desprez PY and Al Moustafa AE: E6/E7 of HPV type 16 promotes
cell invasion and metastasis of human breast cancer cells. Cell
Cycle. 6:2038–2042. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Yang Y, Liou HC and Sun XH: Id1
potentiates NF-kappaB activation upon T cell receptor signaling. J
Biol Chem. 281:34989–34996. 2006. View Article : Google Scholar : PubMed/NCBI
|
